Skip to content
★ Sign in to follow
JM

Jesse McGreivy

Executive
Pharmacyclics Inc
Total declarations
11
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€4.8M

Latest filing published 07 Aug 2014 for PHARMACYCLICS INC, €69k.

Insider track record

Disclosed buys
0
Disclosed sells
4
Signal history

No signal scores available.

Jesse McGreivy: trading record in brief

Jesse McGreivy appears in our data through filings on Pharmacyclics Inc shares, published by SEC (Form 4). In total, 11 filings cover trades dated from 31 October 2012 to 7 August 2014.

The open-market record consists of 4 sales worth €4.8M, with no purchase. Besides market trades, the filings include 6 option exercises. In 2014 alone, the filings show no purchases and 2 sales.

Most recently, on 7 August 2014, the filings show an option exercise worth €69k in Pharmacyclics Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Jesse McGreivy

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total
  • ◇
    Chief Medical OfficerExecutivesPharmacyclics Inc
    92,328 USD0SEC
    3,645 shares@ US$25.33Common StockSEC:0001209191-14-051260:0
  • ◇
    Chief Medical OfficerExecutivesPharmacyclics Inc
    2M USD0SEC
    18,750 shares@ US$89.52Common StockSEC:0001209191-14-051260:1
  • ◇
    Chief Medical OfficerExecutivesPharmacyclics Inc
    718,687 USD0SEC
    11,667 shares@ US$61.60Common StockSEC:0001209191-14-051260:2
  • ▼
    Chief Medical OfficerExecutivesPharmacyclics Inc
    4M USD0SEC
    34,062 shares@ US$120.92Common StockSEC:0001209191-14-051260:3
  • ◇
    Chief Medical OfficerExecutivesPharmacyclics Inc
    166,241 USD0SEC
    6,563 shares@ US$25.33Common StockSEC:0001209191-14-017884:0
  • ▼
    Chief Medical OfficerExecutivesPharmacyclics Inc
    916,589 USD0SEC
    6,563 shares@ US$139.66Common StockSEC:0001209191-14-017884:1
  • ◇
    VP, Clinical ScienceExecutivesPharmacyclics Inc
    240,103 USD0SEC
    9,479 shares@ US$25.33Common StockSEC:0001209191-13-029935:0
  • ◇
    VP, Clinical ScienceExecutivesPharmacyclics Inc
    308,000 USD0SEC
    5,000 shares@ US$61.60Common StockSEC:0001209191-13-029935:1
  • ▼
    VP, Clinical ScienceExecutivesPharmacyclics Inc
    1M USD0SEC
    14,479 shares@ US$91.13Common StockSEC:0001209191-13-029935:2
  • ▼
    VP, Clinical ScienceExecutivesPharmacyclics Inc
    39,230 USD0SEC
    583 shares@ US$67.29Common StockSEC:0001209191-13-003701:0
  • ●
    VP, Clinical ScienceExecutivesPharmacyclics Inc
    13,450 USD0SEC
    583 shares@ US$23.07Common StockSEC:0001209191-12-051555:0

11 of 11 declarations